WASHINGTON (Reuters) -A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, ...

Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to ...

As previously reported last night, Cantor Fitzgerald initiated coverage of five Government Technology & Space, or “GovTech,” stocks, ...

Cantor Fitzgerald analyst Deepak Mathivanan maintained a Buy rating on Pinterest (PINS – Research Report) today and set a price target of ...

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

Lutnick is CEO of Cantor Fitzgerald, previous owner of Cantor Gaming. The company reportedly violated state and federal ...

We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a ...

AST SpaceMobile ( ASTS 5.16%) stock jumped 7.6% through 11:15 a.m. ET Thursday after Cantor Fitzgerald analyst Colin Canfield ...

The Cantor Fitzgerald chair was grilled about prior bullish statements made about Tether during a recent Senate hearing.

Howard Lutnick, a billionaire banker poised to run the Department of Commerce, has deep ties to the crypto industry. But he ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...